title: Lamivudine for chemotherapy-induced reactivation of HBV: prophylaxis or treatment?
authors.forename: Andrea
authors.initials: A
authors.lastname: Mancuso
authors.forename: Luigi
authors.initials: L
authors.lastname: Pagliaro
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects*; D006509:Hepatitis B / Q000188:drug therapy* / Q000517:prevention & control* / Q000821:virology; D006515:Hepatitis B virus / Q000187:drug effects* / Q000502:physiology*; D006801:Humans; D019259:Lamivudine / Q000627:therapeutic use*; D018894:Reverse Transcriptase Inhibitors / Q000627:therapeutic use*; D014775:Virus Activation / Q000187:drug effects*
chemical_list: D000970:Antineoplastic Agents; D018894:Reverse Transcriptase Inhibitors; D019259:Lamivudine